cancer research

In oncology, some milestones arrive with applause. Others arrive quietly. This year, one of the most important cancer drugs of the modern era begins to lose its monopoly. Nivolumab, one of the first PD-1 inhibitors to reach patients, is set…

“I’m a scientist first and foremost. I don’t remember a time not thinking about being a scientist.” What Karen Knudsen, the CEO of Parker Institute for Cancer Immunotherapy, remembers clearly is the pull not toward prestige or power, but toward…

Scientific discovery drives oncology forward, but progress only truly begins when knowledge is turned into action. Every issue of CancerWorld explores the people, ideas, and systems shaping the future of oncology. Scientific breakthroughs remain essential, but their true value emerges…

Chimeric antigen receptor natural killer T (CAR-NKT) cell therapy, a novel form of immunotherapy, is emerging as a promising ‘off-the-shelf’ treatment for patients with pancreatic cancer. In a study published in PNAS, November 21, 2025, U.S. investigators report that CAR-NKT cells…

Where progress is measured not just in science, but in vision, leadership, and care. Every issue of CancerWorld explores people, policies, and practices shaping the future of oncology. In our February issue of CancerWorld, we turn our attention to leadership,…

Each evening, after a day leading one of Italy’s busiest radiotherapy departments, Prof. Andrea Filippi, Head of the Radiation Oncology Unit at the Istituto Nazionale dei Tumori in Milan, and the Associate Professor of Radiation Oncology in the Department of…

If you ask Robert Weinberg how his career began, he will not tell you a story of grand plans or carefully plotted ambition. He will tell you it was “a series of accidents.” “Most people have a series of goals…

Where progress is redesigned with purpose and delivered back to those who need it most Every issue of CancerWorld explores the places where science meets humanity, where personal stories reshape public systems, and where progress in oncology is defined not…

Many people diagnosed with cancer often wonder what “caused” their disease and whether they could have done anything to prevent it. Typically, the risk of developing cancer is determined by a combination of genetics and environmental exposures, causing errors in…

Hello, Dr. Knaul, it’s a great honor to… “Please, call me Felicia,” she interrupted immediately, her warmth cutting through the formality. Felicia Marie Knaul is one of the world’s most influential voices in cancer care advocacy, a leader who doesn’t…